{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:19:30Z","timestamp":1783995570059,"version":"3.55.0"},"reference-count":196,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":533,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada and Sun Life Financial New Investigator Award"},{"DOI":"10.13039\/501100000064","name":"Banting and Best Diabetes Centre, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000064","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIHR Strategy for Patient Oriented Research"},{"name":"Chronic Kidney Disease","award":["CAN-Solve-CKD SCA-145103"],"award-info":[{"award-number":["CAN-Solve-CKD SCA-145103"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1093\/advances\/nmab131","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T08:15:39Z","timestamp":1636100139000},"page":"652-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Lauren","family":"Pickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan-Andrei","family":"Iliuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Scholey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6677-9385","authenticated-orcid":false,"given":"Hoon-Ki","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10174","key":"10.1093\/advances\/nmab131_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le\u00a0Gall","year":"2019","journal-title":"Lancet North Am Ed"},{"issue":"Suppl 4","key":"10.1093\/advances\/nmab131_bib2","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1681\/ASN.2017070819","article-title":"Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease","volume":"29","author":"Nowak","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3109\/0886022X.2015.1033608","article-title":"Association of kidney and cysts dimensions with anthropometric and biochemical parameters in patients with ADPKD","volume":"37","author":"Pietrzak-Nowacka","year":"2015","journal-title":"Ren Fail"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.ackd.2010.01.005","article-title":"Evaluation and management of pain in autosomal dominant polycystic kidney disease","volume":"17","author":"Hogan","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib7","doi-asserted-by":"crossref","first-page":"P536","DOI":"10.1016\/j.xkme.2021.03.004","article-title":"Pain and obesity in autosomal dominant polycystic kidney disease: a post hoc analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) studies","volume":"3","author":"Nowak","year":"2021","journal-title":"Kidney Med"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"issue":"7","key":"10.1093\/advances\/nmab131_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tem.2016.05.002","article-title":"Mitochondria\u2014power players in kidney function?","volume":"27","author":"Forbes","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells plays a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"10.1093\/advances\/nmab131_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41581-019-0183-y","article-title":"The pathobiology of polycystic kidney disease from a metabolic viewpoint","volume":"15","author":"Menezes","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1093\/advances\/nmab131_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","article-title":"Metabolism and mitochondria in polycystic kidney disease research and therapy","volume":"14","author":"Padovano","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1093\/advances\/nmab131_bib13","doi-asserted-by":"crossref","first-page":"109495","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell Signal"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2215\/CJN.13291019","article-title":"Metabolic reprogramming in autosomal dominant polycystic kidney disease","volume":"15","author":"Nowak","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3191","key":"10.1093\/advances\/nmab131_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0925-4439(92)90008-B","article-title":"High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease","volume":"1138","author":"Foxall","year":"1992","journal-title":"Biochim Biophys Acta BBA Mol Basis Dis"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbrc.2017.05.060","article-title":"The changes in glucose metabolism and cell proliferation in the kidneys of polycystic kidney disease mini-pig models","volume":"488","author":"Lian","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib20","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00167.2018","article-title":"Truncating PKHD1 and PKD2 mutations alter energy metabolism","volume":"316","author":"Chumley","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1093\/advances\/nmab131_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib22","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0021-9258(18)64988-9","article-title":"Localization of the primary metabolic block produced by 2-deoxyglucose","volume":"224","author":"Wick","year":"1957","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1093\/advances\/nmab131_bib24","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.2015030231","article-title":"2-Deoxy-d-glucose ameliorates PKD progression","volume":"27","author":"Chiaravalli","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib25","doi-asserted-by":"crossref","first-page":"e0146654","DOI":"10.1371\/journal.pone.0146654","article-title":"Inhibition of aerobic glycolysis attenuates disease progression in polycystic kidney disease","volume":"11","author":"Riwanto","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib26","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1096\/fj.201700909R","article-title":"Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)","volume":"32","author":"Nikonova","year":"2018","journal-title":"FASEB J"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bph.14558","article-title":"The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease","volume":"176","author":"Lian","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-019-0156-8","article-title":"Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism","volume":"5","author":"Zhao","year":"2019","journal-title":"Cell Death Discov"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40620-019-00679-y","article-title":"ADPKD current management and ongoing trials","volume":"33","author":"Testa","year":"2020","journal-title":"J Nephrol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4062\/biomolther.2017.178","article-title":"Targeting glutamine metabolism for cancer treatment","volume":"26","author":"Choi","year":"2018","journal-title":"Biomol Ther"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib31","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41467-018-03036-y","article-title":"Lkb1 deficiency confers glutamine dependency in polycystic kidney disease","volume":"9","author":"Flowers","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/ndt\/gfx349","article-title":"Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease","volume":"33","author":"Soomro","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun Biol"},{"key":"10.1093\/advances\/nmab131_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnut.2020.00021","article-title":"Consideration of ketogenic metabolic therapy as a complementary or alternative approach for managing breast cancer","volume":"7","author":"Seyfried","year":"2020","journal-title":"Front Nutr"},{"key":"10.1093\/advances\/nmab131_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fmed.2020.00065","article-title":"Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases","volume":"7","author":"Jang","year":"2020","journal-title":"Front Med"},{"issue":"11","key":"10.1093\/advances\/nmab131_bib36","doi-asserted-by":"crossref","first-page":"e1003053","DOI":"10.1371\/journal.pgen.1003053","article-title":"Network Analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4\u03b1 as a disease modifier","volume":"8","author":"Menezes","year":"2012","journal-title":"PLos Genet"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-018-9448-1","article-title":"Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle","volume":"19","author":"Knottnerus","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"03","key":"10.1093\/advances\/nmab131_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2007-994309","article-title":"Fetal polycystic kidney disease associated with glutaric aciduria type II: an inborn error of energy metabolism","volume":"13","author":"Whitfield","year":"1996","journal-title":"Am J Perinatol"},{"issue":"7-12","key":"10.1093\/advances\/nmab131_bib39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1699-0463.1998.tb00276.x","article-title":"Recurrent fetal polycystic kidneys associated with glutaric aciduria type II","volume":"106","author":"Kjaergaard","year":"1998","journal-title":"APMIS"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1023\/A:1005556207210","article-title":"Recognition and management of fatty acid oxidation defects: a series of 107 patients","volume":"22","author":"Saudubray","year":"1999","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00467-016-3556-5","article-title":"Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease\u2014different clinical entities and comparable perinatal renal abnormalities","volume":"32","author":"Hackl","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib42","doi-asserted-by":"crossref","first-page":"100056","DOI":"10.1016\/j.xcrm.2020.100056","article-title":"Molecular profiling reveals a common metabolic signature of tissue fibrosis","volume":"1","author":"Zhang","year":"2020","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140695","article-title":"Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis","volume":"131","author":"Miguel","year":"2021","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MNH.0000000000000615","article-title":"The role of PPAR\u03b1 in autosomal dominant polycystic kidney disease","volume":"29","author":"Lakhia","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"13","key":"10.1093\/advances\/nmab131_bib45","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib46","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1038\/ncomms14395","article-title":"microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism","volume":"8","author":"Hajarnis","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib47","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPAR\u03b1 agonist fenofibrate enhances fatty acid \u03b2-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib48","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1681\/ASN.2015060634","article-title":"MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease","volume":"27","author":"Lakhia","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2017070802","article-title":"Impairment of PPAR\u03b1 and the fatty acid oxidation pathway aggravates renal fibrosis during aging","volume":"29","author":"Chung","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1093\/advances\/nmab131_bib50","first-page":"1245","article-title":"The interplay between non-esterified fatty acids and bovine peroxisome proliferator-activated receptors: results of an in vivo-in vitro hybrid approach","volume":"4","author":"Busato","year":"2020","journal-title":"Curr Dev Nutr"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"10.1093\/advances\/nmab131_bib52","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00125-008-1063-3","article-title":"The role of macrophage migration inhibitory factor on glucose metabolism and diabetes","volume":"51","author":"Toso","year":"2008","journal-title":"Diabetologia"},{"key":"10.1093\/advances\/nmab131_bib53","doi-asserted-by":"crossref","first-page":"103965","DOI":"10.1016\/j.cellimm.2019.103965","article-title":"MIF signaling blocking alleviates airway inflammation and airway epithelial barrier disruption in a HDM-induced asthma model","volume":"347","author":"Lan","year":"2020","journal-title":"Cell Immunol"},{"issue":"10","key":"10.1093\/advances\/nmab131_bib54","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2018080846","article-title":"Are cyst-associated macrophages in polycystic kidney disease the equivalent to TAMs in cancer?","volume":"29","author":"Weimbs","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib55","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1172\/JCI80467","article-title":"Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1093\/advances\/nmab131_bib56","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib57","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease progression","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"10.1093\/advances\/nmab131_bib58","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2018050518","article-title":"Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease","volume":"29","author":"Cassini","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"10.1093\/advances\/nmab131_bib59","doi-asserted-by":"crossref","first-page":"e98615","DOI":"10.15252\/embj.201798615","article-title":"Cilia-localized LKB1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney","volume":"37","author":"Viau","year":"2018","journal-title":"EMBO J"},{"issue":"Suppl 1","key":"10.1093\/advances\/nmab131_bib60","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ckj\/sfy089","article-title":"Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease","volume":"11","author":"Weimbs","year":"2018","journal-title":"Clin Kidney J"},{"issue":"5976","key":"10.1093\/advances\/nmab131_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1172539","article-title":"Dietary restriction, growth factors and aging: from yeast to humans","volume":"328","author":"Fontana","year":"2010","journal-title":"Science"},{"key":"10.1093\/advances\/nmab131_bib62","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2147\/CIA.S126458","article-title":"Does eating less make you live longer and better? An update on calorie restriction","volume":"12","author":"Picca","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib63","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1152\/physiol.00030.2019","article-title":"Intermittent fasting: physiological implications on outcomes in mice and men","volume":"35","author":"Lee","year":"2020","journal-title":"Physiology"},{"issue":"6416","key":"10.1093\/advances\/nmab131_bib65","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aau2095","article-title":"A time to fast","volume":"362","author":"Francesco","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib66","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cmet.2015.09.005","article-title":"A smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits","volume":"22","author":"Gill","year":"2015","journal-title":"Cell Metab"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3233\/NHA-170036","article-title":"Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: a pilot study","volume":"4","author":"Gabel","year":"2018","journal-title":"Nutr Healthy Aging"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib68","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cmet.2020.06.018","article-title":"Effects of 4- and 6-h time-restricted feeding on weight and cardiometabolic health: a randomized controlled trial in adults with obesity","volume":"32","author":"Cienfuegos","year":"2020","journal-title":"Cell Metab"},{"issue":"35","key":"10.1093\/advances\/nmab131_bib69","first-page":"1","article-title":"Dietary and physical activity adaptations to alternate day modified fasting: implications for optimal weight loss","volume":"9","author":"Klempel","year":"2010","journal-title":"Nutr J"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib70","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cmet.2018.04.010","article-title":"Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes","volume":"27","author":"Sutton","year":"2018","journal-title":"Cell Metab"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib71","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/oby.22518","article-title":"Early time-restricted feeding reduces appetite and increases fat oxidation but does not affect energy expenditure in humans","volume":"27","author":"Ravussin","year":"2019","journal-title":"Obesity"},{"issue":"9","key":"10.1093\/advances\/nmab131_bib72","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/oby.21581","article-title":"A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity","volume":"24","author":"Catenacci","year":"2016","journal-title":"Obesity"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mcna.2017.08.012","article-title":"Maintenance of lost weight and long-term management of obesity","volume":"102","author":"Hall","year":"2018","journal-title":"Med Clin North Am"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib74","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2012.04.019","article-title":"Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet","volume":"15","author":"Hatori","year":"2012","journal-title":"Cell Metab"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib75","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cmet.2014.11.001","article-title":"Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges","volume":"20","author":"Chaix","year":"2014","journal-title":"Cell Metab"},{"key":"10.1093\/advances\/nmab131_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnut.2020.00039","article-title":"Feeding rhythms and the circadian regulation of metabolism","volume":"7","author":"Pickel","year":"2020","journal-title":"Front Nutr"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib77","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3945\/ajcn.2009.28380","article-title":"Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults","volume":"90","author":"Varady","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcn\/81.1.69","article-title":"Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism","volume":"81","author":"Heilbronn","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib79","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1017\/S0007114513000792","article-title":"The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women","volume":"110","author":"Harvie","year":"2013","journal-title":"Br J Nutr"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib80","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/ijo.2010.171","article-title":"The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women","volume":"35","author":"Harvie","year":"2011","journal-title":"Int J Obes"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib81","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cmet.2019.07.016","article-title":"Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans","volume":"30","author":"Stekovic","year":"2019","journal-title":"Cell Metab"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.metabol.2012.07.002","article-title":"Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet","volume":"62","author":"Klempel","year":"2013","journal-title":"Metabolism"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib83","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cmet.2019.11.004","article-title":"Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome","volume":"31","author":"Wilkinson","year":"2020","journal-title":"Cell Metab"},{"issue":"02","key":"10.1093\/advances\/nmab131_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5414\/CN109102","article-title":"Effects of fasting during the month of Ramadan on renal function in patients with autosomal dominant polycystic kidney disease","volume":"89","author":"Ekinci","year":"2018","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib85","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41467-020-15795-8","article-title":"Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT\/mTOR\/HIF1\u03b1 pathway suppression","volume":"11","author":"Weng","year":"2020","journal-title":"Nat Commun"},{"issue":"26","key":"10.1093\/advances\/nmab131_bib86","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"de\u00a0Cabo","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib87","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib88","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3390\/nu11061234","article-title":"Early time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans","volume":"11","author":"Jamshed","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib89","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cmet.2017.08.005","article-title":"A ketogenic diet extends longevity and healthspan in adult mice","volume":"26","author":"Roberts","year":"2017","journal-title":"Cell Metab"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib90","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2017.08.004","article-title":"Ketogenic diet reduces mid-life mortality and improves memory in aging mice","volume":"26","author":"Newman","year":"2017","journal-title":"Cell Metab"},{"issue":"6416","key":"10.1093\/advances\/nmab131_bib91","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1126\/science.aau2096","article-title":"Dietary fat: from foe to friend?","volume":"362","author":"Ludwig","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13668-018-0235-0","article-title":"Nutritional ketosis for weight management and reversal of metabolic syndrome","volume":"7","author":"Gershuni","year":"2018","journal-title":"Curr Nutr Rep"},{"issue":"Suppl 8","key":"10.1093\/advances\/nmab131_bib93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2008.01821.x","article-title":"History of the ketogenic diet","volume":"49","author":"Wheless","year":"2008","journal-title":"Epilepsia"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib94","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/1028415X.2017.1387721","article-title":"Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: a systematic review and meta-analysis","volume":"22","author":"Rezaei","year":"2019","journal-title":"Nutr Neurosci"},{"key":"10.1093\/advances\/nmab131_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.04.012","article-title":"Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus","volume":"144","author":"Arya","year":"2018","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/epi4.12098","article-title":"Ketogenic diet for treatment of intractable epilepsy in adults: a meta-analysis of observational studies","volume":"3","author":"Liu","year":"2018","journal-title":"Epilepsia Open"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib97","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00415-019-09658-6","article-title":"Effectiveness, retention, and safety of modified ketogenic diet in adults with epilepsy at a tertiary-care centre in the UK","volume":"267","author":"Green","year":"2020","journal-title":"J Neurol"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/nu12020333","article-title":"Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure","volume":"12","author":"Bruci","year":"2020","journal-title":"Nutrients"},{"issue":"10","key":"10.1093\/advances\/nmab131_bib99","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.nut.2012.01.016","article-title":"Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes","volume":"28","author":"Hussain","year":"2012","journal-title":"Nutrition"},{"issue":"9","key":"10.1093\/advances\/nmab131_bib100","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1038\/nutd.2016.36","article-title":"Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus","volume":"6","author":"Goday","year":"2016","journal-title":"Nutr Diabetes"},{"issue":"21","key":"10.1093\/advances\/nmab131_bib101","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa022207","article-title":"A randomized trial of a low-carbohydrate diet for obesity","volume":"348","author":"Foster","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/advances\/nmab131_bib102","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nutres.2018.11.007","article-title":"Weight loss, improved physical performance, cognitive function, eating behavior, and metabolic profile in a 12-week ketogenic diet in obese adults","volume":"62","author":"Mohorko","year":"2019","journal-title":"Nutr Res"},{"key":"10.1093\/advances\/nmab131_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2020.02.010","article-title":"Impact of ketosis on appetite regulation\u2014a review","volume":"77","author":"Deemer","year":"2020","journal-title":"Nutr Res"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib104","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jacl.2019.08.003","volume":"13","author":"Kirkpatrick","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/obr.12230","article-title":"Do ketogenic diets really suppress appetite? A systematic review and meta-analysis","volume":"16","author":"Gibson","year":"2015","journal-title":"Obes Rev"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib106","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/ijo.2017.96","article-title":"Timeline of changes in appetite during weight loss with a ketogenic diet","volume":"41","author":"Nymo","year":"2017","journal-title":"Int J Obes"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib107","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib108","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1038\/s41598-018-20856-6","article-title":"A cleavage product of polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib109","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cmet.2018.08.011","article-title":"Daily fasting improves health and survival in male mice independent of diet composition and calories","volume":"29","author":"Mitchell","year":"2019","journal-title":"Cell Metab"},{"key":"10.1093\/advances\/nmab131_bib110","doi-asserted-by":"crossref","first-page":"100206","DOI":"10.1016\/j.phanu.2020.100206","article-title":"GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a modified Atkins diet in autosomal dominant polycystic kidney disease patients","volume":"13","author":"Testa","year":"2020","journal-title":"PharmaNutrition"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib111","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1528-1167.2006.00438.x","article-title":"A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy","volume":"47","author":"Kossoff","year":"2006","journal-title":"Epilepsia"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3988\/jcn.2015.11.1.26","article-title":"Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis","volume":"11","author":"Ye","year":"2015","journal-title":"J Clin Neurol"},{"key":"10.1093\/advances\/nmab131_bib113","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1016\/j.phanu.2019.100154","article-title":"A pilot study to evaluate tolerability and safety of a modified Atkins diet in ADPKD patients","volume":"9","author":"Testa","year":"2019","journal-title":"PharmaNutrition"},{"key":"10.1093\/advances\/nmab131_bib114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnut.2020.00020","article-title":"Consumer reports of \u201cketo flu\u201d associated with the ketogenic diet","volume":"7","author":"Bostock","year":"2020","journal-title":"Front Nutr"},{"key":"10.1093\/advances\/nmab131_bib115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2015.10.017","article-title":"The effect of the ketogenic diet on the vascular structure and functions in children with intractable epilepsy","volume":"56","author":"\u00d6zdemir","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1093\/advances\/nmab131_bib116","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nut.2016.06.016","article-title":"Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy","volume":"33","author":"Azevedo\u00a0de\u00a0Lima","year":"2017","journal-title":"Nutrition"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib117","first-page":"200","article-title":"Long-term effects of a ketogenic diet in obese patients","volume":"9","author":"Dashti","year":"2004","journal-title":"Exp Clin Cardiol"},{"issue":"7","key":"10.1093\/advances\/nmab131_bib118","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jama.290.7.912","article-title":"Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children","volume":"290","author":"Peter","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib119","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ejpn.2014.03.006","article-title":"Effects of ketogenic diet on vascular function","volume":"18","author":"Kapetanakis","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib120","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.clnu.2017.11.001","article-title":"10 patients, 10 years\u2014long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with ketogenic diet therapies: a prospective, multicenter case series","volume":"37","author":"Heussinger","year":"2018","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib121","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.kint.2018.12.023","article-title":"Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease","volume":"95","author":"Alan","year":"2019","journal-title":"Kidney Int"},{"key":"10.1093\/advances\/nmab131_bib122","doi-asserted-by":"crossref","first-page":"104506","DOI":"10.1016\/j.yrtph.2019.104506","article-title":"Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults","volume":"109","author":"Soto-Mota","year":"2019","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1093\/advances\/nmab131_bib123","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphys.2017.00848","article-title":"On the metabolism of exogenous ketones in humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front Physiol"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib124","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1113\/JP275709","article-title":"Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals","volume":"596","author":"Myette-C\u00f4t\u00e9","year":"2018","journal-title":"J Physiol"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib125","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/ajcn\/nqz232","article-title":"A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial","volume":"110","author":"Myette-C\u00f4t\u00e9","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib126","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3945\/ajcn.116.133561","article-title":"Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men","volume":"104","author":"Hall","year":"2016","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib127","doi-asserted-by":"crossref","first-page":"E1724","DOI":"10.1152\/ajpendo.00717.2006","article-title":"A high-fat, ketogenic diet induces a unique metabolic state in mice","volume":"292","author":"Kennedy","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"41","key":"10.1093\/advances\/nmab131_bib128","doi-asserted-by":"crossref","first-page":"66444","DOI":"10.18632\/oncotarget.12119","article-title":"\u03b2-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation","volume":"7","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPAR\u03b1 and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"issue":"12","key":"10.1093\/advances\/nmab131_bib130","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/ijms17122093","article-title":"Regulation of ketone body metabolism and the role of PPAR\u03b1","volume":"17","author":"Grabacka","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1093\/advances\/nmab131_bib131","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3390\/nu11102497","article-title":"Ketogenic diet: a new light shining on old but gold biochemistry","volume":"11","author":"Longo","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib132","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1528-1167.2011.02981.x","article-title":"The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway","volume":"52","author":"McDaniel","year":"2011","journal-title":"Epilepsia"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib133","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/bj1120149","article-title":"The fuel of respiration of rat kidney cortex","volume":"112","author":"Weidemann","year":"1969","journal-title":"Biochem J"},{"key":"10.1093\/advances\/nmab131_bib134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnut.2020.00013","article-title":"Metabolism of exogenous D-beta-hydroxybutyrate, an energy substrate avidly consumed by the heart and kidney","volume":"7","author":"Cuenoud","year":"2020","journal-title":"Front Nutr"},{"key":"10.1093\/advances\/nmab131_bib135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib136","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/jnc.12975","article-title":"The metabolic impact of \u03b2-hydroxybutyrate on neurotransmission: reduced glycolysis mediates changes in calcium responses and KATP channel receptor sensitivity","volume":"132","author":"Lund","year":"2015","journal-title":"J Neurochem"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib137","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cmet.2016.07.010","article-title":"Nutritional ketosis alters fuel preference and thereby endurance performance in athletes","volume":"24","author":"Cox","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib138","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.metabol.2015.10.001","article-title":"Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2","volume":"65","author":"Graff","year":"2016","journal-title":"Metabolism"},{"issue":"11","key":"10.1093\/advances\/nmab131_bib139","doi-asserted-by":"crossref","first-page":"11894","DOI":"10.1096\/fj.201901080R","article-title":"Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms","volume":"33","author":"Felizardo","year":"2019","journal-title":"FASEB J"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000499741","article-title":"Podocyte injury in autosomal dominant polycystic kidney disease","volume":"142","author":"Cebeci","year":"2019","journal-title":"Nephron"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib141","first-page":"246","article-title":"Cell-surface G-protein-coupled receptors for tumor-associated metabolites: a direct link to mitochondrial dysfunction in cancer","volume":"1868","author":"Ristic","year":"2017","journal-title":"Biochim Biophys Acta"},{"issue":"6116","key":"10.1093\/advances\/nmab131_bib142","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib143","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"\u03b2-Hydroxybutyrate: a signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"10.1093\/advances\/nmab131_bib144","doi-asserted-by":"crossref","first-page":"109509","DOI":"10.1016\/j.cellsig.2019.109509","article-title":"Epigenetics and cell cycle regulation in cystogenesis","volume":"68","author":"Li","year":"2020","journal-title":"Cell Signal"},{"issue":"51","key":"10.1093\/advances\/nmab131_bib145","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.1073\/pnas.0911987106","article-title":"Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models","volume":"106","author":"Cao","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1093\/advances\/nmab131_bib146","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"10.1093\/advances\/nmab131_bib147","doi-asserted-by":"crossref","first-page":"109594","DOI":"10.1016\/j.cellsig.2020.109594","article-title":"The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease","volume":"71","author":"Kurbegovic","year":"2020","journal-title":"Cell Signal"},{"issue":"10","key":"10.1093\/advances\/nmab131_bib148","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/ijms20102415","article-title":"p53 at the crossroads between different types of HDAC inhibitor-mediated cancer cell death","volume":"20","author":"Mrakovcic","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1093\/advances\/nmab131_bib149","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.20892\/j.issn.2095-3941.2018.0170","article-title":"p53 mutation regulates PKD genes and results in co-occurrence of PKD and tumorigenesis","volume":"16","author":"Li","year":"2019","journal-title":"Cancer Biol Med"},{"issue":"9","key":"10.1093\/advances\/nmab131_bib151","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1002\/jcp.26473","article-title":"MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR\/MDM2 pathway in ADPKD cells","volume":"233","author":"De\u00a0Stephanis","year":"2018","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib152","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ekir.2020.06.002","article-title":"Biological efficacy and safety of niacinamide in patients with ADPKD","volume":"5","author":"El\u00a0Ters","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib153","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","article-title":"Metabolic regulation of gene expression by histone lysine \u03b2-hydroxybutyrylation","volume":"62","author":"Xie","year":"2016","journal-title":"Mol Cell"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1463-y","article-title":"p53 \u03b2-hydroxybutyrylation attenuates p53 activity","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib155","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1681\/ASN.V134991","article-title":"Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease","volume":"13","author":"Maser","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib156","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1681\/ASN.2018010039","article-title":"Lipid peroxidation drives renal cyst growth in vitro through activation of TMEM16A","volume":"30","author":"Schreiber","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib157","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/iub.1997","article-title":"The \u201cgreat\u201d controlling nucleotide coenzymes","volume":"71","author":"Veech","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1093\/advances\/nmab131_bib158","doi-asserted-by":"crossref","first-page":"5157645","DOI":"10.1155\/2018\/5157645","article-title":"Nutritional ketosis and mitohormesis: potential implications for mitochondrial function and human health","volume":"2018","author":"Miller","year":"2018","journal-title":"J Nutr Metab"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib159","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2014.04.074","article-title":"Protective effects of exogenous \u03b2-hydroxybutyrate on paraquat toxicity in rat kidney","volume":"447","author":"Wei","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1093\/advances\/nmab131_bib160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.18632\/aging.100683","article-title":"D-beta-hydroxybutyrate extends lifespan in C. elegans","volume":"6","author":"Edwards","year":"2014","journal-title":"Aging"},{"issue":"554","key":"10.1093\/advances\/nmab131_bib161","doi-asserted-by":"crossref","first-page":"eaba3613","DOI":"10.1126\/scitranslmed.aba3613","article-title":"Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease","volume":"12","author":"Lu","year":"2020","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1093\/advances\/nmab131_bib162","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/jn\/130.9.2356","article-title":"High dietary fat intake increases renal cyst disease progression in Han:SPRD-cy rats","volume":"130","author":"Jayapalan","year":"2000","journal-title":"J Nutr"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib163","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11745-004-1221-7","article-title":"Modulation of renal injury in pcy mice by dietary fat containing n\u22123 fatty acids depends on the level and type of fat","volume":"39","author":"Sankaran","year":"2004","journal-title":"Lipids"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib164","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jn\/133.1.180","article-title":"Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats","volume":"133","author":"Lu","year":"2003","journal-title":"J Nutr"},{"issue":"12","key":"10.1093\/advances\/nmab131_bib165","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/nure.12085","article-title":"Evidence for a role of proteins, lipids, and phytochemicals in the prevention of polycystic kidney disease progression and severity","volume":"71","author":"Maditz","year":"2013","journal-title":"Nutr Rev"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib166","doi-asserted-by":"crossref","first-page":"e0155790","DOI":"10.1371\/journal.pone.0155790","article-title":"Lack of benefit of early intervention with dietary flax and fish oil and soy protein in orthologous rodent models of human hereditary polycystic kidney disease","volume":"11","author":"Yamaguchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1093\/advances\/nmab131_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2017.07.002","article-title":"Distinct effects of dietary flax compared to fish oil, soy protein compared to casein, and sex on the renal oxylipin profile in models of polycystic kidney disease","volume":"123","author":"Devassy","year":"2017","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib168","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.kint.2020.02.012","article-title":"The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo","volume":"98","author":"Lannoy","year":"2020","journal-title":"Kidney Int"},{"key":"10.1093\/advances\/nmab131_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.02.012","article-title":"Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update","volume":"58","author":"Albracht-Schulte","year":"2018","journal-title":"J Nutr Biochem"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib170","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clnu.2019.03.032","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: A systematic review and meta-analysis","volume":"39","author":"Jang","year":"2020","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib171","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1523-1755.1999.00287.x","article-title":"Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease","volume":"55","author":"Ogborn","year":"1999","journal-title":"Kidney Int"},{"issue":"11","key":"10.1093\/advances\/nmab131_bib172","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11745-002-1001-4","article-title":"Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n-6\/n-3 FA ratio in experimental polycystic kidney disease","volume":"37","author":"Ogborn","year":"2002","journal-title":"Lipids"},{"issue":"12","key":"10.1093\/advances\/nmab131_bib173","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s11745-006-5064-z","article-title":"Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender","volume":"41","author":"Ogborn","year":"2006","journal-title":"Lipids"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib174","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1203\/01.pdr.0000245912.78078.d5","article-title":"Dietary flax oil during pregnancy and lactation retards disease progression in rat offspring with inherited kidney disease","volume":"60","author":"Sankaran","year":"2006","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/mnfr.201300332","article-title":"Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat","volume":"58","author":"Ibrahim","year":"2014","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib176","first-page":"335","article-title":"Effects of dietary supplementation with n-3 fatty acids on kidney morphology and the fatty acid composition of phospholipids and triglycerides from mice with polycystic kidney disease","volume":"69","author":"Yamaguchi","year":"1990","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"11","key":"10.1093\/advances\/nmab131_bib177","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0271-5317(05)80537-8","article-title":"Effects of dietary fish oil on survival and renal fatty acid composition in murine polycystic kidney disease","volume":"12","author":"Aukema","year":"1992","journal-title":"Nutr Res"},{"issue":"9","key":"10.1093\/advances\/nmab131_bib178","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/ndt\/gfn144","article-title":"The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD","volume":"23","author":"Higashihara","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1093\/advances\/nmab131_bib179","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","article-title":"Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group","volume":"5","author":"Klahr","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib180","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int"},{"issue":"3","key":"10.1093\/advances\/nmab131_bib181","first-page":"F541","article-title":"Soy protein modification of rat polycystic kidney disease","volume":"274","author":"Ogborn","year":"1998","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib182","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1523-1755.2000.00835.x","article-title":"Modification of polycystic kidney disease and fatty acid status by soy protein diet","volume":"57","author":"Ogborn","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib183","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1523-1755.2001.00465.x","article-title":"Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats","volume":"59","author":"Aukema","year":"2001","journal-title":"Kidney Int"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib184","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/jn\/134.6.1504","article-title":"Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats","volume":"134","author":"Fair","year":"2004","journal-title":"J Nutr"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S0007114507250470","article-title":"Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring","volume":"97","author":"Cahill","year":"2007","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1093\/advances\/nmab131_bib186","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1159\/000104836","article-title":"Late dietary intervention limits benefits of soy protein or flax oil in experimental polycystic kidney disease","volume":"106","author":"Sankaran","year":"2007","journal-title":"Nephron Exp Nephrol"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib187","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0272-6386(96)90525-9","article-title":"Modification of disease progression in rats with inherited polycystic kidney disease","volume":"27","author":"Cowley","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib188","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.V561355","article-title":"Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease","volume":"5","author":"Tomobe","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib189","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/ajkd.1998.v31.pm9428452","article-title":"Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease","volume":"31","author":"Tomobe","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1681\/ASN.V102300","article-title":"Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level","volume":"10","author":"Aukema","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib191","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.kint.2017.01.021","article-title":"Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease","volume":"92","author":"Yamamoto","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1093\/advances\/nmab131_bib192","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.clnu.2016.01.003","article-title":"Diet and polycystic kidney disease: a pilot intervention study","volume":"36","author":"Taylor","year":"2017","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1093\/advances\/nmab131_bib193","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.ajkd.2016.07.023","article-title":"Low osmolar diet and adjusted water intake for vasopressin reduction in autosomal dominant polycystic kidney disease: a pilot randomized controlled trial","volume":"68","author":"Amro","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1093\/advances\/nmab131_bib194","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/nu11071576","article-title":"Dietary care for ADPKD patients: current status and future directions","volume":"11","author":"Carriazo","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"10.1093\/advances\/nmab131_bib195","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40620-018-0470-x","article-title":"Nutritional therapy in autosomal dominant polycystic kidney disease","volume":"31","author":"Di\u00a0Iorio","year":"2018","journal-title":"J Nephrol"},{"issue":"1","key":"10.1093\/advances\/nmab131_bib196","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12882-017-0641-3","article-title":"Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease","volume":"18","author":"Tran","year":"2017","journal-title":"BMC Nephrology"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/advances\/advance-article-pdf\/doi\/10.1093\/advances\/nmab131\/42078726\/nmab131.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/advances\/article-pdf\/13\/2\/652\/43177895\/nmab131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/advances\/article-pdf\/13\/2\/652\/43177895\/nmab131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:56:17Z","timestamp":1761872177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831322000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":196,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2161831322000825"],"URL":"https:\/\/doi.org\/10.1093\/advances\/nmab131","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/advances\/nmab131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 \u00a9 The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}